Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

3.

HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.

Guo R, Li Y, Ning J, Sun D, Lin L, Liu X.

PLoS One. 2013 Apr 29;8(4):e62729. doi: 10.1371/journal.pone.0062729. Print 2013.

4.

Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.

Mayeda A, Helfman DM, Krainer AR.

Mol Cell Biol. 1993 May;13(5):2993-3001. Erratum in: Mol Cell Biol 1993 Jul;13(7):4458.

5.

Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.

Eperon IC, Makarova OV, Mayeda A, Munroe SH, Cáceres JF, Hayward DG, Krainer AR.

Mol Cell Biol. 2000 Nov;20(22):8303-18.

6.

hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.

Expert-Bezançon A, Sureau A, Durosay P, Salesse R, Groeneveld H, Lecaer JP, Marie J.

J Biol Chem. 2004 Sep 10;279(37):38249-59. Epub 2004 Jun 18.

7.

Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.

Hanamura A, Cáceres JF, Mayeda A, Franza BR Jr, Krainer AR.

RNA. 1998 Apr;4(4):430-44.

8.

Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.

Zerbe LK, Pino I, Pio R, Cosper PF, Dwyer-Nield LD, Meyer AM, Port JD, Montuenga LM, Malkinson AM.

Mol Carcinog. 2004 Dec;41(4):187-96.

PMID:
15390079
9.

Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.

Cáceres JF, Stamm S, Helfman DM, Krainer AR.

Science. 1994 Sep 16;265(5179):1706-9.

PMID:
8085156
10.

Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.

Rooke N, Markovtsov V, Cagavi E, Black DL.

Mol Cell Biol. 2003 Mar;23(6):1874-84.

11.
12.

Spatial and temporal expression of the myometrial mitogen-activated protein kinases p38 and ERK1/2 in the human uterus during pregnancy and labor.

Otun HA, MacDougall MW, Bailey J, Europe-Finner GN, Robson SC.

J Soc Gynecol Investig. 2005 Apr;12(3):185-90.

PMID:
15784503
13.

Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins.

Mayeda A, Munroe SH, Cáceres JF, Krainer AR.

EMBO J. 1994 Nov 15;13(22):5483-95.

14.
15.

Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.

Boukakis G, Patrinou-Georgoula M, Lekarakou M, Valavanis C, Guialis A.

BMC Cancer. 2010 Aug 17;10:434. doi: 10.1186/1471-2407-10-434.

17.
18.

Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.

Blanco FJ, Bernabeu C.

Aging Cell. 2011 Oct;10(5):896-907. doi: 10.1111/j.1474-9726.2011.00727.x. Epub 2011 Jul 19.

19.

Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.

Mayeda A, Krainer AR.

Cell. 1992 Jan 24;68(2):365-75.

PMID:
1531115
20.

Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1.

Bai Y, Lee D, Yu T, Chasin LA.

Nucleic Acids Res. 1999 Feb 15;27(4):1126-34.

Supplemental Content

Support Center